Share
Market Research Report

MOSQUITO BORNE DISEASE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Disease TypeMalaria · Dengue · Yellow Fever · West Nile Virus · Chikungunya · Zika Virus · and Others
  • By Treatment TypeMedication · Vaccination · Vector Control Methods · Immunotherapy · Supportive Care · and Others
  • By End UserHospitals · Clinics · Diagnostic Centers · Research Institutes · Government Organizations · NGOs · and Others
  • By GeographyNorth America · Latin America · Europe · Asia Pacific · Middle East & Africa
  • Published In29 Apr 2026
  • Report CodeCMI6241
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Mosquito Borne Disease, By Disease Type
      • Market Mosquito Borne Disease, By Treatment Type
      • Market Mosquito Borne Disease, By End User
      • Market Mosquito Borne Disease, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Impact Analysis
    • Key Highlights
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
  4. Global Mosquito Borne Disease Market, By Disease Type, 2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Malaria
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Dengue 
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Yellow Fever
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • West Nile Virus
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Chikungunya
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Zika Virus
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  5. Global Mosquito Borne Disease Market, By Treatment Type, 2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Medication
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Vaccination
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Vector Control Methods
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bin)
    • Immunotherapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Supportive Care
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  6. Global Mosquito Borne Disease Market, By End User, 2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Diagnostic Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Research Institutes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Government Organizations
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • NGOs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  7. Global Mosquito Borne Disease Market, By Region, 2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, By Region, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, For Region, 2022 –2033
      • Country Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Bn)
        • South Africa
        • North Africa
        • Central Africa
  8. Competitive Landscape

    • GlaxoSmithKline plc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Sanofi S.A.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Pfizer Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Merck & Co., Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Novartis AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Johnson & Johnson
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Eisai Co., Ltd
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Takeda Pharmaceutical Company Limited
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • AstraZeneca
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Valeant Pharmaceuticals International, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Mitsubishi Tanabe Pharma Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Abbott
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Hoffmann-La Roche Ltd
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Sun Pharmaceutical Industries Ltd
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Lupin Pharmaceuticals, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • BioCryst Pharmaceuticals, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Mallinckrodt Pharmaceuticals
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Serum Institute of India Pvt. Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • CSL Limited
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Teva Pharmaceutical Industries Ltd
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Analyst Views
  9. Section

    • Research Methodology
    • About us

*Browse 46 market data tables and 42 figures on “Global Mosquito Borne Disease Market” - Global forecast to 2033